Prevalence of Atopic Dermatitis, Asthma and Rhinitis from Infancy Through Adulthood in Rural Bangladesh: a Population-based, Cross-sectional Survey
Overview
Affiliations
Objective: Describe the pattern of atopic disease prevalence from infancy to adulthood.
Design: Cross-sectional household survey.
Setting: Community-based demographic surveillance site, Mirzapur, Bangladesh.
Participants: 7275 individuals in randomly selected clusters within 156 villages.
Primary And Secondary Outcome Measures: The 12-month prevalence of atopic dermatitis (by UK Working Party Criteria (UK criteria) and International Study of Asthma and Allergies in Childhood (ISAAC)), asthma and rhinitis (by ISAAC); disease severity (by ISAAC); history of ever receiving a medical diagnosis.
Results: Children aged 2 years had the highest prevalence of atopic dermatitis-18.8% (95% CI 15.2% to 22.4%) by UK criteria and 14.9% (95% CI 11.6% to 18.1%) by ISAAC- and asthma (20.1%, 95% CI 16.4% to 23.8%). Prevalence of rhinitis was highest among 25-29 year olds (6.0%, (95% CI% 4.5 to 7.4%). History of a medical diagnosis was lowest for atopic dermatitis (4.0%) and highest for rhinitis (27.3%) and was significantly associated with severe disease compared with those without severe disease for all three conditions (atopic dermatitis: 30.0% vs 11.7%, p=0.015; asthma; 85.0% vs 60.4%, p<0.001; rhinitis: 34.2% vs 7.3%, p<0.001) and having a higher asset-based wealth score for asthma (29.7% (highest quintile) vs 7.5% (lowest quintile), p<0.001) and rhinitis (39.8% vs 12.5%, p=0.003). Prevalence of having 1 condition was highest (36.2%) at 2 years and decreased with age. Having atopic dermatitis (ISAAC) was associated with significantly increased odds ratios (OR) for comorbid asthma (OR 5.56 (95% CI 4.26 to 7.26)] and rhinitis (3.68 (95% CI 2.73 to 4.96)). Asthma and rhinitis were also strongly associated with each other (OR 8.39 (95% CI 6.48 to 10.86)).
Conclusions: Atopic disease burden was high in this rural Bangladeshi population. Having one atopic condition was significantly associated with the presence of another. Low incidence of ever obtaining a medical diagnosis highlights an important opportunity to increase availability of affordable diagnosis and treatment options for all age groups.
Marques G, Amaral A, Passos V, Weber P, Oliveira P, Menezes A J Bras Pneumol. 2024; 50(6):e20240317.
PMID: 39699516 PMC: 11601083. DOI: 10.36416/1806-3756/e20240317.
Individual- and system-level determinants of breastfeeding in a low-resource setting.
Loutet M Front Public Health. 2024; 12:1471252.
PMID: 39568606 PMC: 11576276. DOI: 10.3389/fpubh.2024.1471252.
Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.
Gurgel R, Baroody F, Damask C, Mims J, Ishman S, Baker D Otolaryngol Head Neck Surg. 2024; 170(3):635-667.
PMID: 38408153 PMC: 11748194. DOI: 10.1002/ohn.650.
Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.
Gurgel R, Baroody F, Damask C, Mims J, Ishman S, Baker Jr D Otolaryngol Head Neck Surg. 2024; 170 Suppl 1:S1-S42.
PMID: 38408152 PMC: 11788925. DOI: 10.1002/ohn.648.
Rakhshanda S, Abedin M, Wahab A, Barua L, Faruque M, Banik P BMJ Open. 2023; 13(12):e074195.
PMID: 38070896 PMC: 10729215. DOI: 10.1136/bmjopen-2023-074195.